All In Biotech

Drug Trial Radar · NCT01993940

Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy

Last checked: Nov 20, 2026Latest source record: May 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 553 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

553

Actual

Start

Nov 4, 2013

Primary completion

Jun 9, 2015

Study completion Jun 9, 2015

Sponsor

Lead sponsor
ShionogiIndustry
Sponsor type
Industry
First posted
Nov 25, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of naldemedine in the treatment of opioid-induced constipation (OIC) in adults with non-malignant chronic pain who are not using laxatives.

Conditions

  • Opioid-induced Constipation

Interventions

  • NaldemedineDrug

    Naldemedine 0.2 mg tablet taken orally once a day

  • PlaceboDrug

    Placebo tablet taken orally once a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With a Spontaneous Bowel Movement (SBM) ResponseTime frame: 12-week treatment period

Locations

49 sites in 1 country. Site status is shown where the registry gives one.

  • Shionogi Research Site

    Birmingham, Alabama

  • Shionogi Research Site

    Homewood, Alabama

  • Shionogi Research Site

    Goodyear, Arizona

  • Shionogi Research Site

    Little Rock, Arkansas

  • Shionogi Research Site

    Anaheim, California

  • Shionogi Research Site

    Buena Park, California

  • Shionogi Research Site

    Corona, California

  • Shionogi Research Site

    Gold River, California

  • Shionogi Research Site

    Los Angeles, California

  • Shionogi Research Site

    Modesto, California

  • Shionogi Research Site

    Pasadena, California

  • Shionogi Research Site

    Coral Gables, Florida

  • Shionogi Research Site

    Hialeah, Florida

  • Shionogi Research Site

    Jacksonville, Florida

  • Shionogi Research Site

    Miami, Florida

  • Shionogi Research Site

    Miami Beach, Florida

  • Shionogi Research Site

    Plantation, Florida

  • Shionogi Research Site

    Columbus, Georgia

  • Shionogi Research Site

    Evansville, Indiana

  • Shionogi Research Site

    Indianapolis, Indiana

  • Shionogi Research Site

    West Des Moines, Iowa

  • Shionogi Research Site

    Edgewood, Kentucky

  • Shionogi Research Site

    Crowley, Louisiana

  • Shionogi Research Site

    Kalamazoo, Michigan

  • Shionogi Research Site

    Traverse City, Michigan

  • Shionogi Research Site

    Butte, Montana

  • Shionogi Research Site

    Omaha, Nebraska

  • Shionogi Research Site

    Las Vegas, Nevada

  • Shionogi Research Site

    Omaha, Nevada

  • Shionogi Research Site

    Albuquerque, New Mexico

  • Shionogi Research Site

    Hopewell Junction, New York

  • Shionogi Research Site

    Mooresville, North Carolina

  • Shionogi Research Site

    Winston-Salem, North Carolina

  • Shionogi Research Site

    Dayton, Ohio

  • Shionogi Research Site

    Marion, Ohio

  • Shionogi Research Site

    Media, Pennsylvania

  • Shionogi Research Site

    Spartanburg, South Carolina

  • Shionogi Research Site

    Knoxville, Tennessee

  • Shionogi Research Site

    Tullahoma, Tennessee

  • Shionogi Research Site

    Channelview, Texas

Showing 40 of 49 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.